Difference between revisions of "U-50488"

From Self-sufficiency
Jump to: navigation, search
m (Stub sorting and placement of stub template(s): hallucinogen-stub)
 
m (1 revision)
 
(No difference)

Latest revision as of 10:22, 20 September 2010

U-50488
200px
Systematic (IUPAC) name
2-(3,4-dichlorophenyl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide
Identifiers
CAS Number 67198-13-4
PubChem CID 3036289
IUPHAR/BPS 1652
Chemical data
Formula C19H26Cl2N2O
Molar mass 369.329 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

U-50488 is a drug which acts as a highly selective κ-opioid agonist, but without any μ-opioid antagonist effects.[1] It has analgesic, diuretic and antitussive effects,[2] and reverses the memory impairment produced by anticholinergic drugs.[3] U-50488 was one of the first selective kappa agonists invented and research on its derivatives has led to the development of a large family of related compounds.[4][5]



References

  1. Von Voigtlander PF, Lewis RA. U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists. Progress in Neuropsychopharmacology and Biological Psychiatry. 1982;6(4-6):467-70. PMID 6298890
  2. Kamei J. Role of opioidergic and serotonergic mechanisms in cough and antitussives. Pulmonary Pharmacology. 1996 Oct-Dec;9(5-6):349-56. PMID 9232674
  3. Hiramatsu M, Kameyama T. Roles of kappa-opioid receptor agonists in learning and memory impairment in animal models. Methods and Findings in Experimental and Clinical Pharmacology. 1998 Sep;20(7):595-9. PMID 9819804
  4. Szmuszkovicz J. U-50,488 and the kappa receptor: a personalized account covering the period 1973 to 1990. Progress in Drug Research. 1999;52:167-95. PMID 10396128
  5. Szmuszkovicz J. U-50,488 and the kappa receptor. Part II: 1991-1998. Progress in Drug Research. 1999;53:1-51. PMID 10616295